http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-142881-A5
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba090c867801ab7bccb082f1b694ad25 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 |
| filingDate | 1979-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6afa823c2079c1d14f09d1230850e819 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09b5bed31af86adab0b8bb7c099844e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5909727192b1ed1e6847837769cf436f |
| publicationDate | 1980-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DD-142881-A5 |
| titleOfInvention | PROCESS FOR THE PRODUCTION OF PYRIMIDONES |
| abstract | The invention relates to a process for the preparation of pyrimidones of the general formula II, in which the radicals Het 1, Υ, z, A, R and r 1 have the meanings given in the invention. These compounds are drugs that act as histamine H-j and histamine H antagonists and have reduced toxicity. The compounds can be used in the control of histamine-induced excessive gastric acid secretion, inflammation, and histamine-induced blood pressure effects. Formula II |
| priorityDate | 1979-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 161.